Literature DB >> 6317890

Analysis of the herpes simplex virus genome during in vitro latency in human diploid fibroblasts and rat sensory neurons.

B Wigdahl, A C Scheck, R J Ziegler, E De Clercq, F Rapp.   

Abstract

We have previously designed in vitro model systems to characterize the herpes simplex virus type 1 (HSV-1) genome during in vitro virus latency. Latency was established by treatment of infected human embryo lung fibroblast (HEL-F) cells or rat fetal neurons with (E)-5-(2-bromovinyl)-2'-deoxyuridine and human leukocyte interferon and was maintained by increasing the incubation temperature after inhibitor removal. Virus was reactivated by reducing the incubation temperature. We have now examined the HSV-1-specific DNA content of latently infected HEL-F cells and rat fetal neurons treated with (E)-5-(2-bromovinyl)-2'-deoxyuridine and human leukocyte interferon and increased temperature. The HEL-F cell population contained, on an average, between 0.25 and 0.5 copies of most, if not all, HSV-1 HindIII and XbaI DNA fragments per haploid cell genome equivalent. In contrast, the latently infected neurons contained, on an average, 8 to 10 copies per haploid cell genome equivalent of most HSV-1 BamHI DNA fragments. There was no detectable alteration in size or molarity of the HSV-1 terminal or junction DNA fragments obtained by HindIII, XbaI, or BamHI digestion of the latently infected neuron or HEL-F cell DNA, as compared with digestion of a reconstruction mixture of purified HSV-1 virion and HEL-F cell DNAs. These data suggest that the predominant form of the HSV-1 genome in either latently infected cell population is nonintegrated, linear, and nonconcatameric.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6317890      PMCID: PMC255443     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Peripheral infection in culture of rat sensory neurons by herpes simplex virus.

Authors:  R J Ziegler; R E Herman
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

2.  Early events required for induction of chromosome abnormalities in human cells by herpes simplex virus.

Authors:  F J O'Neill; F Rapp
Journal:  Virology       Date:  1971-06       Impact factor: 3.616

3.  Synergistic effect of herpes simplex virus and cytosine arabinoside on human chromosomes.

Authors:  F J O'Neill; F Rapp
Journal:  J Virol       Date:  1971-05       Impact factor: 5.103

4.  Molecular genetics of herpes simplex virus. VI. Characterization of a temperature-sensitive mutant defective in the expression of all early viral gene products.

Authors:  D M Knipe; W Batterson; C Nosal; B Roizman; A Buchan
Journal:  J Virol       Date:  1981-05       Impact factor: 5.103

5.  Cloning of reiterated and nonreiterated herpes simplex virus 1 sequences as BamHI fragments.

Authors:  L E Post; A J Conley; E S Mocarski; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

6.  Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus.

Authors:  E De Clercq; J Descamps; G Verhelst; R T Walker; A S Jones; P F Torrence; D Shugar
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

7.  Reactivation of herpes simplex virus type 2 from a quiescent state by human cytomegalovirus.

Authors:  A M Colberg-Poley; H C Isom; F Rapp
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

8.  Persistence of herpes simplex virus genes in cells of neuronal origin.

Authors:  M Levine; A L Goldin; J C Glorioso
Journal:  J Virol       Date:  1980-07       Impact factor: 5.103

9.  Involvement of an early human cytomegalovirus function in reactivation of quiescent herpes simplex virus type 2.

Authors:  A M Colberg-Poley; H C Isom; F Rapp
Journal:  J Virol       Date:  1981-03       Impact factor: 5.103

10.  A light and electron microscope study of long-term organized cultures of rat dorsal root ganglia.

Authors:  M B Bunge; R P Bunge; E R Peterson; M R Murray
Journal:  J Cell Biol       Date:  1967-02       Impact factor: 10.539

View more
  14 in total

1.  Characterization of a potent refractory state and persistence of herpes simplex virus 1 in cell culture.

Authors:  Cristina Barreca; Peter O'Hare
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 2.  Current status review: molecular biology of herpes simplex virus latency.

Authors:  D S Latchman
Journal:  J Exp Pathol (Oxford)       Date:  1990-02

Review 3.  Experimental investigation of herpes simplex virus latency.

Authors:  E K Wagner; D C Bloom
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

Review 4.  Human herpesviruses: a consideration of the latent state.

Authors:  J G Stevens
Journal:  Microbiol Rev       Date:  1989-09

5.  Fusion of the termini of the murine cytomegalovirus genome after infection.

Authors:  J R Marks; D H Spector
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

6.  Detection of herpes simplex virus-specific DNA sequences in latently infected mice and in humans.

Authors:  S Efstathiou; A C Minson; H J Field; J R Anderson; P Wildy
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

7.  Suppression of herpes simplex virus type 1 reactivation from latency by (+-)-9-([(Z)-2-(hydroxymethyl)cyclohexyl]methyl) guanine (L-653,180) in vitro.

Authors:  Y A Nsiah; R L Tolman; J D Karkas; F Rapp
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

8.  Efficient quiescent infection of normal human diploid fibroblasts with wild-type herpes simplex virus type 1.

Authors:  Robert McMahon; Derek Walsh
Journal:  J Virol       Date:  2008-08-13       Impact factor: 5.103

9.  Herpes simplex virus latency in isolated human neurons.

Authors:  B Wigdahl; C A Smith; H M Traglia; F Rapp
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

10.  Suppression of herpes simplex virus 1 in MDBK cells via the interferon pathway.

Authors:  Cristina Barreca; Peter O'Hare
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.